https://www.selleckchem.com/pr....oducts/-r-s--3-5-dhp
Data for 50 patients undergoing 3-port VATS lobectomy were analyzed. Intraoperative remifentanil consumption did not differ significantly between Group D (n = 25, 715.62 ± 320.36 μg) and group S (n = 25, 721.08 ± 294.48 μg) (P = .97). Additionally, there were no significant differences between the 2 groups in SBP and HR at any time point, emergence time, or amount of rescue drugs used. Our study suggests that the intraoperative analgesic efficacy is similar for deep and superficial SAPB during VATS lobectomy. Our study suggests t